CUSIP 464288836U.S. PHARMA ETFIHEQ4 2025
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fisher Asset Management, LLC | 2.83M | $239.70M |
| 2 | Foundations Investment Advisors, LLC | 642.6K | $54.51M |
| 3 | Morgan Stanley | 472.6K | $40.09M |
| 4 | Bank Of America Corp /De/ | 444.0K | $37.67M |
| 5 | Jpmorgan Chase & Co | 212.8K | $18.05M |
| 6 | Royal Bank Of Canada | 157.0K | $13.31M |
| 7 | Lpl Financial LLC | 137.7K | $11.69M |
| 8 | Anfield Capital Management, LLC | 118.0K | $10.01M |
| 9 |
| Bnp Paribas Financial Markets |
| 103.0K |
| $8.74M |
| 10 | Goldman Sachs Group Inc | 82.9K | $7.03M |